http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2663687-C2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8633111d019dbfe69eeca111037d1e36 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-337 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5169 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-337 |
filingDate | 2013-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2018-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f7340399465cfccefaff443b6dc837f3 |
publicationDate | 2018-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2663687-C2 |
titleOfInvention | Nanoparticle compositions of albumin and paclitaxel |
abstract | FIELD: medicine. n SUBSTANCE: group of inventions relates to medicine and relates to a pharmaceutical composition for the treatment of a proliferative disease in a subject, comprising nanoparticles containing albumin and paclitaxel, in which no more than about 2.4% of said albumin in the pharmaceutical composition is in the form of polymers. Group of inventions also relates to a method of treating cancer in a subject, comprising administering to the subject an effective amount of a pharmaceutical composition. n EFFECT: group of inventions provides an albumin polymer/monomer profile, most suitable for use in the treatment of cancer. n 31 cl, 5 ex, 9 tbl |
priorityDate | 2012-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 77.